David Turkaly
Stock Analyst at Citizens
(2.19)
# 2,831
Out of 5,115 analysts
144
Total ratings
40.15%
Success rate
-3.32%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Upgrades: Market Outperform | $440 | $369.56 | +19.06% | 4 | Dec 19, 2025 | |
| TELA TELA Bio | Maintains: Market Outperform | $7 → $5 | $1.00 | +400.00% | 7 | Nov 14, 2025 | |
| APYX Apyx Medical | Upgrades: Market Outperform | $8 | $4.02 | +99.00% | 6 | Nov 12, 2025 | |
| AXGN Axogen | Maintains: Market Outperform | $26 → $34 | $34.85 | -2.44% | 8 | Oct 30, 2025 | |
| KIDS OrthoPediatrics | Maintains: Market Outperform | $35 → $25 | $17.45 | +43.27% | 12 | Oct 10, 2025 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $112 → $73 | $66.92 | +9.09% | 9 | Aug 7, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $13.23 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $90.68 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $66.66 | +50.02% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $262.60 | +6.63% | 18 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $35 → $25 | $11.14 | +124.42% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $62 → $55 | $22.04 | +149.55% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $140 → $125 | $87.07 | +43.56% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $400 → $500 | $441.41 | +13.27% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $104.37 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $16.59 | +92.89% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $6.93 | +130.88% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $2.09 | +43.54% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $9.03 | -44.63% | 1 | Oct 6, 2017 |
Stryker
Dec 19, 2025
Upgrades: Market Outperform
Price Target: $440
Current: $369.56
Upside: +19.06%
TELA Bio
Nov 14, 2025
Maintains: Market Outperform
Price Target: $7 → $5
Current: $1.00
Upside: +400.00%
Apyx Medical
Nov 12, 2025
Upgrades: Market Outperform
Price Target: $8
Current: $4.02
Upside: +99.00%
Axogen
Oct 30, 2025
Maintains: Market Outperform
Price Target: $26 → $34
Current: $34.85
Upside: -2.44%
OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $17.45
Upside: +43.27%
Lantheus Holdings
Aug 7, 2025
Maintains: Market Outperform
Price Target: $112 → $73
Current: $66.92
Upside: +9.09%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $13.23
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $90.68
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $66.66
Upside: +50.02%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $262.60
Upside: +6.63%
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $11.14
Upside: +124.42%
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $22.04
Upside: +149.55%
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $87.07
Upside: +43.56%
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $441.41
Upside: +13.27%
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $104.37
Upside: -
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $16.59
Upside: +92.89%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $6.93
Upside: +130.88%
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $2.09
Upside: +43.54%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $9.03
Upside: -44.63%